himself
The modern biographical story of Stanislaw Burzynski, MD, PhD who discovered an innovative patent-protected cancer therapy currently enrolled in FDA clinical trials. This story sheds light on the current regulatory and industry roadblocks preventing these life-saving medications from reaching the market as of 2016. The current story of Stanislaw Burzynski, MD, PhD who discovered an innovative cancer therapy now enrolled in FDA clinical trials, and the regulatory and industry roadblocks preventing these life-saving medications from reaching the market.
In the compelling follow-up to the internationally award-winning documentary, "Burzynski: the Movie,", Part II explores the current status of Antineoplastons' clinical testing sanctioned by the United States Food & Drug Administration - and features a modern story of the struggling journeys of cancer patients being treated today at the Burzynski Clinic in Houston, Texas. Since the mapping of the Cancer Genome, Burzynski has pioneered an expansion of his therapy, which he calls, "Personalized Gene-Targeted Cancer Therapy", where each patient's Genomic Cancer Atlas is mapped and a treatment regimen is personally tailored for each individual patient - vs. the conveyor belt, "one-size-fits-all" approach that current oncology adheres to.
